Xeltis
Last verified 2026-05-23. JSON
The funding figures on this page are attributed, not sourced: a publisher is on record but no document URL is. How we mark provenance.
| Total raised | $21.6Mattributed |
|---|---|
| Latest round | grant, $21.6M, 2025-04-01attributed |
| Founded | 2007 |
| Headquarters | Eindhoven, Netherlands |
| Industry | medtech |
| Stage | unknown |
| Website | xeltis.com |
Endogenous tissue restoration (ETR) polymer platform for restorative cardiovascular devices including heart valves and vascular grafts.
Funding rounds
| Date | Round | Amount | Lead |
|---|---|---|---|
| 2025-04-01 | grant | $21.6M | undisclosed |
Detected tech stack
Nginx, WordPress 7.0, Yoast SEO 27.6, Google Analytics, Google Tag Manager, Slider Revolution, jQuery Migrate 3.4.1, imagesLoaded 4.1.4, parallax.js, PHP, DoubleClick Floodlight, Onsen UI
Provenance
| Fact | Status | Basis |
|---|---|---|
| Grant, $21.6M | attributed | eu-grant named as publisher. No document URL on file. |
| Total raised $21.6M | attributed | eu-grant named as publisher. No document URL on file. |
| Company existence | self-reported | xeltis.com, read 2026-05-23 |
| Description | self-reported | xeltis.com, read 2026-05-23 |
Nothing on this page is sourced yet. A sourced fact links to a document that states it.
Change history
No change recorded since records began on 2026-09-24.